FindTrial
Sign In

Efficacy of BCAA and Vitamin D Enriched Nutritional Support for Resistance Training in Elderly Patients with Sarcopenia; A Single center, Randomized, Open-Label, Comparative Study

Efficacy of BCAA and Vitamin D Enriched Nutritional Support for Resistance Training in Elderly Patients with Sarcopenia; A Single center, Randomized, Open-Label, Comparative Study - Efficacy of BCAA and Vitamin D Enriched Nutritional Support for Resistance Training in Elderly Patients with Sarcopenia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006238
Enrollment
100
Registered
2011-09-01
Start date
2011-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Resistance training with Dietary Supplement
Resource PemPal ACTIVE Resistance training

Sponsors

Sakurajyuji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Elderly patients over 65 years of age hospitalized in Sakurajyuji-Hospital, Recovery rehabilitation unit, since September 2011. 2.Diagnosed of sarcopenia by measurement of AMA; AMA<28.32cm2 for male, AMA<20.93cm2 for female (JARD 2011,5th percentile of AMA) 3.Good general condition 4.Good wakefulness (Japan coma scale<I-1) 5.Appropriate nutritional management (Energy administration meets TEE)

Exclusion criteria

Exclusion criteria: 1.Uncontrolled co-morbidities 2.Severe dementia (Revised Hasegawa's dementia scale; HDS-R<10 points) 3.Severe renal dysfunction (eGFR<60)

Design outcomes

Primary

MeasureTime frame
The change in Physical function. Measured by Barthel Index (BI) and Functional Independence Measure (FIM). Assessment in baseline and three months after treatment.—

Secondary

MeasureTime frame
1.Muscle mass (AMA,AC,AMC,CC) 2.Muscle strength (MMT) 3.Nutritional assessment (MNA,BMI,Alb,Hb,T-Cho,ChE,TLC,BUN,Cr,vitamin-D,CRP) 4.Cognitive function (HDS-R,FIM) Assessment in baseline and three months after treatment.—

Countries

Japan

Contacts

Public ContactYoshihiro Yoshimura

Sakurajyuji Hospital medical office

hanley.belfus@gmail.com

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026